Myomo (MYO) Interest Expenses (2020)
Myomo (MYO) reported Interest Expenses of $12135.0 for Q3 2020, down 69.68% quarter-over-quarter from $40025.0 in Q2 2020.
Myomo (MYO) Interest Expenses (2020) Analysis & Trends
Myomo has reported Interest Expenses for 1 years, with the latest figure at $12135.0 in Q3 2020.
- For the quarter ending Q3 2020, Interest Expenses changed N/A year-over-year to $12135.0; the trailing twelve-month figure through Jun 2021 stood at $12135.0 (down 94.13% YoY), and the FY2020 full-year result was $218803.0, up 92.56% from the prior year.
- Interest Expenses for Q3 2020 stood at $12135.0, down from $40025.0 in the prior quarter.
- The five-year high for Interest Expenses was $166643.0 in Q1 2020, with the low at $12135.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 174.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 181.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 90.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -97.17 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.10 Mn |
| 10 | Myomo | 49.44 Mn | 31.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 12,135.00 |
| Sep 30, 2020 | 12,135.00 |
| Jun 30, 2020 | 40,025.00 |
| Jun 30, 2020 | 40,025.00 |
| Mar 31, 2020 | 166,643.00 |
| Mar 31, 2020 | 166,643.00 |